Rate Benchmarking
Compare your rates with similar providers.
Select a published rate, define comparable providers, and see where that rate falls in your market.
See a sample rate comparisonHCPCS J2360 (Orphenadrine Citrate) Fee Schedule
Medicare rates as of October 2026
HCPCS J2360 is classified under Drugs Administered Other than Oral Method, in the Drugs, Administered by Injection subgroup.
Injection, orphenadrine citrate, up to 60 mg
| Key Fact | Detail |
|---|---|
| Service Type | Drugs Administered Other than Oral Method Drugs, Administered by Injection |
| Common Place of Service | 11 - Office 20 - Urgent Care Facility |
| Complexity Level | Low |
| Medicare Fee Schedule | $6.27 per up to 60 mg (October 2026 ASP) · View Medicare rates for J2360 |
| Medicaid Fee Schedule | $7.775 median of the 8 states in the free preview · View Medicaid rates for J2360 |
| Medicare Payment Limit | $11.186  |
| WAC Price | Lorem ipsum dolor sit amet consectetur Lorem ipsum dolor sit amet consectetur VisitBuyandBill.com |
| Related NDC Codes | • 00641-6182-10 - ORPHENADRINE CITRATE 30 MG/1 ML • 00641-6182-25 - ORPHENADRINE CITRATE (PF,LATEX-FREE) 30 MG/1 ML • 51927-2118-00 - ORPHENADRINE CITRATE (USP) • 55553-0129-10 - ANTIFLEX (AMP) 30 MG/ML |
National average reimbursement for HCPCS J2360 by major payers:
$10.62
BCBS / Anthem
$9.22
UnitedHealthcare
$10.04
Aetna
$9.53
Cigna
Compare published rates across providers.
Choose a payer to see a sample of rates for HCPCS J2360.
HCPCS J2360
5 of 25 sample ratesHigher to lower in this preview
Lij-Ns Health System
Long Island Jewish Medical Center
$20.98Published rateUPMC Altoona, Altoona Family Physicians
UPMC
$14.69Published rateLas Vegas Vamc
$13.98Published rateRichmond Vamc
$9.09Published rateHilo Medical Center
$4.71Published rate
Get a free rate benchmark for your specialty.
Choose your state and specialty to build a report from payer-published rates.
Use market rates to prepare your payer proposal.
Payer Contract Negotiation
Draft a fee schedule renegotiation letter.
Use your fee schedule and market benchmarks to set target rates and draft a letter for your payer.
See a sample payer proposalHCPCS J2360 vs. Other Drugs, Administered by Injection Codes
The table lists codes related to J2360. Select one to see its fee schedule.
| Code | Complexity | Description |
|---|---|---|
| 00641-6182-10-NDC | Moderate | ORPHENADRINE CITRATE 30 MG/1 ML |
| 00641-6182-25-NDC | Moderate | ORPHENADRINE CITRATE (PF,LATEX-FREE) 30 MG/1 ML |
| 51927-2118-00-NDC | Moderate | ORPHENADRINE CITRATE (USP) |
| J2360-HCPCS | Low | Injection, orphenadrine citrate, up to 60 mg |
What is a fee schedule?
A fee schedule is a list of fixed prices that healthcare providers charge for specific services, including HCPCS J2360. These prices vary depending on payer type (Medicare, Medicaid, private insurance), geographic location, and provider contracts.
Understanding the J2360 fee schedule helps patients estimate costs and providers optimize billing for accurate reimbursements.
Factors that affect fee schedules
Medicare & Medicaid Rates
Government-set reimbursement amounts
Private Insurance Rates
Negotiated rates between providers and insurance companies
Geographic Location
Costs may be higher in urban areas.
Provider Type
Hospital providers may have different rates than private practice.
FREE SAMPLE MARKET COMPARISON
Let's review your payer contracts side-by-side with the market.
Bring your top codes (like HCPCS J2360) and we'll show you how you compare in 15 minutes or less.